Red-Hot Life Sciences Real Estate Investment Market Poised for Further Growth
Investment in U.S. lab and R&D properties has grown by 111% since 2018, with the bulk of that growth occurring in 2021 (+62% from 2020), which exceeded the previous peak year (2007) by 108%. Investment volume growth of at least 10% is forecast for 2022, based on historical trends, the current pipeline and intelligence from CBRE Capital Markets professionals.
RELATED POSTS
-
July 25, 2024
Where Are the Women in Investment Sales?
Other areas of the industry have diversified in recent years — not so the field of trading buildings and sites […]
Read More -
July 24, 2024
SL Green Lands $500M Refi for 919 Third Avenue
SL Green Realty has landed a $500 million refinancing for its 47-story office building at 919 Third Avenue, the landlord announced Wednesday. Credit […]
Read More -
July 24, 2024
2023 Notable Leaders in Real Estate
Darcy Stacom serves as chairman and head of New York City capital markets at CBRE, overseeing sales, financing, joint ventures […]
Read More